Vertex Pharmaceuticals Inc (VRTX)
471.12
-4.86
(-1.02%)
USD |
NASDAQ |
Nov 01, 16:00
471.00
-0.12
(-0.03%)
After-Hours: 20:00
Vertex Pharmaceuticals Gross Profit Margin (Quarterly): 85.94% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 85.94% |
| March 31, 2024 | 87.27% |
| December 31, 2023 | 85.38% |
| September 30, 2023 | 87.17% |
| June 30, 2023 | 87.62% |
| March 31, 2023 | 88.76% |
| December 31, 2022 | 87.70% |
| September 30, 2022 | 87.60% |
| June 30, 2022 | 88.08% |
| March 31, 2022 | 88.28% |
| December 31, 2021 | 88.06% |
| September 30, 2021 | 88.08% |
| June 30, 2021 | 87.29% |
| March 31, 2021 | 88.85% |
| December 31, 2020 | 87.52% |
| September 30, 2020 | 87.90% |
| June 30, 2020 | 87.90% |
| March 31, 2020 | 89.27% |
| December 31, 2019 | 86.91% |
| September 30, 2019 | 86.11% |
| June 30, 2019 | 85.58% |
| March 31, 2019 | 88.92% |
| December 31, 2018 | 85.95% |
| September 30, 2018 | 85.82% |
| June 30, 2018 | 86.12% |
| Date | Value |
|---|---|
| March 31, 2018 | 88.82% |
| December 31, 2017 | 87.10% |
| September 30, 2017 | 87.40% |
| June 30, 2017 | 86.91% |
| March 31, 2017 | 93.43% |
| December 31, 2016 | 86.81% |
| September 30, 2016 | 86.93% |
| June 30, 2016 | 89.52% |
| March 31, 2016 | 87.28% |
| December 31, 2015 | 84.83% |
| September 30, 2015 | 89.68% |
| June 30, 2015 | 89.85% |
| March 31, 2015 | 91.11% |
| December 31, 2014 | 90.30% |
| September 30, 2014 | 92.08% |
| June 30, 2014 | 87.50% |
| March 31, 2014 | 86.93% |
| December 31, 2013 | 93.66% |
| September 30, 2013 | 87.67% |
| June 30, 2013 | 87.79% |
| March 31, 2013 | 86.98% |
| December 31, 2012 | 73.74% |
| September 30, 2012 | 88.53% |
| June 30, 2012 | 72.65% |
| March 31, 2012 | 91.06% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
85.38%
Minimum
Dec 2023
89.27%
Maximum
Mar 2020
87.66%
Average
87.70%
Median
Dec 2022
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 81.02% |
| Bristol-Myers Squibb Co | 75.13% |
| Regeneron Pharmaceuticals Inc | 86.80% |
| Sarepta Therapeutics Inc | 87.73% |
| Moderna Inc | 47.96% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.96% |
| Return on Assets | -2.25% |
| Return on Invested Capital | -2.96% |
| Profit Margin (Quarterly) | -135.8% |
| Operating Margin (Quarterly) | 35.34% |
| Return on Net Operating Assets | -8.40% |